[Severe anaphylaxis associated with rocuronium administration].
Bermejo Alvarez
M A
MA
Carpintero
M
M
Cosío
F
F
Fervienza
P
P
Castañón
E
E
D000368:Aged; D000707:Anaphylaxis / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy; D000732:Androstanols / Q000008:administration & dosage / Q000009:adverse effects*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D003608:Dacryocystorhinostomy; D004562:Electrocardiography; D004837:Epinephrine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007431:Intraoperative Complications / Q000139:chemically induced* / Q000188:drug therapy; D008297:Male; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D003473:Neuromuscular Nondepolarizing Agents / Q000008:administration & dosage / Q000009:adverse effects*; D005996:Nitroglycerin / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D011292:Premedication; D000077123:Rocuronium
D000732:Androstanols; D001993:Bronchodilator Agents; D003473:Neuromuscular Nondepolarizing Agents; D005996:Nitroglycerin; D006854:Hydrocortisone; D000077123:Rocuronium; D004837:Epinephrine